tiprankstipranks
IGC Pharma (IGC)
:IGC
US Market

IGC Pharma (IGC) Financial Statements

Compare
891 Followers

IGC Pharma Financial Overview

IGC Pharma's market cap is currently $24.42M. The company's EPS TTM is $-0.122; its P/E ratio is ―; IGC Pharma is scheduled to report earnings on February 12, 2025, and the estimated EPS forecast is $-0.02. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Mar 23Mar 22Mar 21Mar 20
Income Statement
Total Revenue$ 1.34M$ 911.00K$ 397.00K$ 898.00K$ 4.07M
Gross Profit$ 733.00K$ 442.00K$ 194.00K$ 113.00K$ 115.00K
Operating Income$ -9.80M$ -11.57M$ -15.43M$ -8.72M$ -6.86M
EBITDA$ -9.16M$ -10.91M$ -14.78M$ -8.25M$ -6.72M
Net Income$ -13.00M$ -11.44M$ -14.60M$ -8.98M$ -8.10M
Balance Sheet
Cash & Short-Term Investments$ 1.20M$ 3.35M$ 10.46M$ 14.63M$ 12.34M
Total Assets$ 9.90M$ 17.18M$ 26.83M$ 35.87M$ 28.98M
Total Debt$ 345.00K$ 481.00K$ 488.00K$ 985.00K$ 535.00K
Net Debt$ -853.00K$ -2.71M$ -9.97M$ -13.56M$ -6.72M
Total Liabilities$ 2.58M$ 2.27M$ 2.94M$ 3.06M$ 2.45M
Stockholders' Equity$ 7.32M$ 14.91M$ 23.89M$ 32.80M$ 26.54M
Cash Flow
Free Cash Flow$ -5.71M$ -7.67M$ -8.20M$ -12.39M$ -13.14M
Operating Cash Flow$ -5.20M$ -7.05M$ -7.46M$ -10.80M$ -8.68M
Investing Cash Flow$ -317.00K$ -235.00K$ -742.00K$ 3.39M$ -9.55M
Financing Cash Flow$ 3.52M$ 100.00K$ 4.14M$ 14.69M$ -59.00K
Currency in USD

IGC Pharma Earnings and Revenue History

IGC Pharma Debt to Assets

IGC Pharma Cash Flow

IGC Pharma Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis